Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rietschel

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
Psychological Medicine|March 7, 2012
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorderR Uher, S Carver, R A Power, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 14, 2001
Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?T G Schulze, D J Müller, H Krauss, et al.
Molecular Psychiatry|January 7, 2015
Identification and functional characterization of rare SHANK2 variants in schizophreniaS Peykov, S Berkel, M Schoen, et al.
Molecular Psychiatry|June 6, 2012
The psychiatric vulnerability gene CACNA1C and its sex-specific relationship with personality traits, resilience factors and depressive symptoms in the general populationJ Strohmaier, M Amelang, L A Hothorn, et al.
Molecular Psychiatry|July 24, 2009
Supporting evidence for LRRTM1 imprinting effects in schizophreniaK U Ludwig, M Mattheisen, T W Mühleisen, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 30, 2000
Dopamine D3 receptor variant and tardive dyskinesiaM Rietschel, H Krauss, D J Müller, et al.
American Journal of Medical Genetics|July 23, 1998
Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysisS G Schwab, J Hallmayer, M Albus, et al.
Pharmacopsychiatry|May 8, 2003
CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patientsP L Lohmann, M Bagli, H Krauss, et al.
Pharmacopsychiatry|November 17, 2011
The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depressionN Dreimüller, A Tadić, A Dragicevic, et al.
Molecular Psychiatry|July 13, 2000
Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)F Grünhage, T G Schulze, D J Müller, et al.
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
Psychological Medicine|March 7, 2012
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorderR Uher, S Carver, R A Power, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 14, 2001
Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?T G Schulze, D J Müller, H Krauss, et al.
Molecular Psychiatry|January 7, 2015
Identification and functional characterization of rare SHANK2 variants in schizophreniaS Peykov, S Berkel, M Schoen, et al.
Molecular Psychiatry|June 6, 2012
The psychiatric vulnerability gene CACNA1C and its sex-specific relationship with personality traits, resilience factors and depressive symptoms in the general populationJ Strohmaier, M Amelang, L A Hothorn, et al.
Molecular Psychiatry|July 24, 2009
Supporting evidence for LRRTM1 imprinting effects in schizophreniaK U Ludwig, M Mattheisen, T W Mühleisen, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 30, 2000
Dopamine D3 receptor variant and tardive dyskinesiaM Rietschel, H Krauss, D J Müller, et al.
American Journal of Medical Genetics|July 23, 1998
Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysisS G Schwab, J Hallmayer, M Albus, et al.
Pharmacopsychiatry|May 8, 2003
CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patientsP L Lohmann, M Bagli, H Krauss, et al.
Pharmacopsychiatry|November 17, 2011
The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depressionN Dreimüller, A Tadić, A Dragicevic, et al.
Molecular Psychiatry|July 13, 2000
Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)F Grünhage, T G Schulze, D J Müller, et al.
Pageof 21